HCW Biologics Inc.
HCWB · Healthcare · $587,514
After-hours $1.69-3.43%
Price
$4.58
$1.75
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
3/'26
Revenue$7M+23965.2%
Operating Income$3MTurned profitable
Net Income$3M+382.8%
12/'25 vs prev quarter
Company Health
Market Cap$587,514
Operating Margin-98.5%
Cash on Hand$1M209.2% of market cap
Free Cash Flow$-11M-1949.4% of market cap
Short Float 3.1% · biweekly · settled 26.09.15
Among 326 Biotechnology peers
LowMedianHigh
PSR0.1xmedian 11.1xPBR0.1xmedian 2.0xROE-39.8%median -54.5%HCW Biologics Announces Pricing of $1.5 Million Private Placement5d ago
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T CellsSep 8
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata TreatmentSep 2
HCW Biologics' TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased CellsAug 25
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial ResultsAug 14
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement OfferingJul 29
